CAT.INIST
Accueil du sitewww.cnrs.frwww.inist.frOther CNRS


COMMANDER / ORDER
PARTAGER / SHARE
EXPORT
Bookmark and Share
Mendeley    EndNote

Titre du document / Document title

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

Auteur(s) / Author(s)

CARLENS S. (1 2) ; RINGDEN O. (1 2) ; REMBERGER M. (1) ; LÖNNQVIST B. (3) ; HÄGGLUND H. (2) ; KLAESSON S. (4) ; MATTSSON J. (2) ; SVAHN B.-M. (2) ; WINIARSKI J. (4) ; LJUNGMAN P. (3) ; ASCHAN J. (3) ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

(1) Department of Clinical Immunology, Huddinge Hospital, Huddinge, SUEDE
(2) Department of Transplantation Surgery, Huddinge Hospital, Huddinge, SUEDE
(3) Department of Haematology, Huddinge Hospital, Huddinge, SUEDE
(4) Department of Paediatrics, Huddinge Hospital, Huddinge, SUEDE

Résumé / Abstract

Among 551 consecutive recipients of allogeneic bone marrow transplants, 451 survived more than 3 months and were evaluated for chronic graft-versus-host disease (GVHD). Most of the donors were HLA-identical siblings or parents (n = 334). Patients with HLA-mismatched donors (n = 30) and matched unrelated donors (MUD) (n = 87) were also included in the study. In the analysis of all patients, the 5-year cumulative incidence of chronic GVHD was 45%. We analysed 34 risk factors. High recipient age was the single most important risk factor (P < 0.001). Other significant risk factors in multivariate analysis were: acute GVHD grades I-IV (P < 0.001), immune female donor to male recipient (P = 0.006) and chronic myelogenous leukaemia (CML), compared with all other diagnoses (P = 0.014). The cumulative 5-year incidence of chronic GVHD, with no significant risk factors present, was 9%, 29% with one risk factor, 53% with two, 68% with three and 75% with all four risk factors present. In patients with HLA-identical sibling donors and GVHD prophylaxis consisting of a combination of methotrexate (MTX) and cyclosporin A (CsA) (n = 208), increasing recipient age (P < 0.001) and CML (P = 0.007), were found to be significant risk factors for chronic GVHD. Finally, a multivariate analysis in recipients of bone marrow from unrelated donors (n = 89) showed recipient age alone (P = 0.006) to be significantly associated with chronic GVHD.

Revue / Journal Title

Bone marrow transplantation   ISSN 0268-3369   CODEN BMTRE9 

Source / Source

1998, vol. 22, no8, pp. 755-761 (46 ref.)

Langue / Language

Anglais

Editeur / Publisher

Nature Publishing Group , Basingstoke, ROYAUME-UNI  (1986) (Revue)

Mots-clés anglais / English Keywords

Homograft ; Graft ; Bone marrow ; Graft versus host reaction ; Chronic ; Complication ; Risk factor ; Retrospective ; Human ; Immunopathology ;

Mots-clés français / French Keywords

Homogreffe ; Greffe ; Moelle osseuse ; Maladie greffon hôte ; Chronique ; Complication ; Facteur risque ; Rétrospective ; Homme ; Immunopathologie ;

Mots-clés espagnols / Spanish Keywords

Homoinjerto ; Injerto ; Médula ósea ; Enfermedad injerto huesped ; Crónico ; Complicación ; Factor riesgo ; Retrospectiva ; Hombre ; Inmunopatología ;

Localisation / Location

INIST-CNRS, Cote INIST : 21176, 35400007149298.0040

Nº notice refdoc (ud4) : 2416135

COMMANDER / ORDER
PARTAGER / SHARE
EXPORT
Bookmark and Share
Mendeley    EndNote

CAT.INIST